HomeBUSINESS
BUSINESS

Santen Files Omidenepag Isopropyl for Glaucoma, Ocular Hypertension in Japan
(Nov.28.2017)

Santen Pharmaceutical and Ube Industries said on November 27 that Santen has filed a new drug application for the glaucoma and ocular hypertension treatment omidenepag isopropyl (development code: DE-117) in Japan ...
(LOG IN FOR FULL STORY)

News Calendar